206 results on '"Capece Daria"'
Search Results
2. Apoptosis in mesenchymal stromal cells activates an immunosuppressive secretome predicting clinical response in Crohn’s disease
3. The tumor suppressor gene KCTD11REN is regulated by Sp1 and methylation and its expression is reduced in tumors
4. NF-κB: blending metabolism, immunity, and inflammation
5. Systems level profiling of chemotherapy-induced stress resolution in cancer cells reveals druggable trade-offs
6. Evidence of the Link between Stroma Remodeling and Prostate Cancer Prognosis.
7. NF-κB: Governing Macrophages in Cancer
8. NF-κB: Governing Innate Immunity in Cancer
9. The Screening of Combinatorial Peptide Libraries for Targeting Key Molecules or Protein–Protein Interactions in the NF-κB Pathway
10. Extracellular Flux Analysis to Investigate the Impact of NF-κB on Mitochondrial Respiration in Colorectal Carcinoma (CRC)
11. Immunohistochemical Analysis of Expression, Phosphorylation, and Nuclear Translocation of NF-κB Proteins in Human Tissues
12. Biochemical Methods to Analyze the Subcellular Localization of NF-κB Proteins Using Cell Fractionation
13. Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3
14. Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression
15. Acyl-Carnitines Exert Positive Effects on Mitochondrial Activity under Oxidative Stress in Mouse Oocytes: A Potential Mechanism Underlying Carnitine Efficacy on PCOS
16. Life, death, and autophagy in cancer: NF-κB turns up everywhere
17. Enhanced triacylglycerol catabolism by carboxylesterase 1 promotes aggressive colorectal carcinoma
18. Figure S4 from GADD45β Loss Ablates Innate Immunosuppression in Cancer
19. Data from GADD45β Loss Ablates Innate Immunosuppression in Cancer
20. Supplementary information from GADD45β Loss Ablates Innate Immunosuppression in Cancer
21. Reprogramming immunosuppressive tumour-associated dendritic cells with GADD45β inhibitors
22. Intracellular Chloride Channels Regulate Endothelial Metabolic Reprogramming in Pulmonary Arterial Hypertension
23. Effects of osteoblast-derived extracellular vesicles on aggressiveness, redox status and mitochondrial bioenergetics of MNNG/HOS osteosarcoma cells
24. The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target
25. NF-κB: A Druggable Target in Acute Myeloid Leukemia
26. Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer
27. EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?
28. The Glycosaminoglycan-Binding Domain of PRELP Acts as a Cell Type—Specific NF-κB Inhibitor That Impairs Osteoclastogenesis
29. Rewired lipid metabolism as an actionable vulnerability of aggressive colorectal carcinoma
30. Ultrasound-Based Method for the Identification of Novel MicroRNA Biomarkers in Prostate Cancer
31. The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-[kappa]B inhibitor that impairs osteoclastogenesis
32. Low Radiation Environment Switches the Overgrowth-Induced Cell Apoptosis Toward Autophagy
33. Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs
34. NF-κB and mitochondria cross paths in cancer: mitochondrial metabolism and beyond
35. Cancer-selective targeting of the NF-?B survival pathway with GADD45ß/MKK7 inhibitors
36. Clinical proof of concept for a safe and effective NF ‐κB‐targeting strategy in multiple myeloma
37. Cancer secretome and inflammation: The bright and the dark sides of NF-κB
38. Turning an old GADDget into a troublemaker
39. GADD45β Loss Ablates Innate Immunosuppression in Cancer
40. NF-κB in the crosshairs: Rethinking an old riddle
41. Next-generation sequencing: recent applications to the analysis of colorectal cancer
42. Additional file 1: Figure S1. of MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice
43. Additional file 2: Figure S2. of MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice
44. Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve Specificity
45. Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a NAFLD/NASH mouse model
46. Clinical proof of concept for a safe and effective NF‐κB‐targeting strategy in multiple myeloma.
47. MicroRNAs in the DNA Damage/Repair Network and Cancer
48. Cancer-Selective Targeting of the NF-kappa B Survival Pathway with GADD45 beta/MKK7 Inhibitors
49. Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach?
50. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.